Of the nine transcription factors, six (ZBTB33, YY1, TAF1, E2F1, SF1, and ZNF143) were significantly highly expressed in the NAFLD patients with FDR < 0.05 and fold change > 1.8. Here, YY1 is linked to metabolic dysfunction-associated steatotic liver disease.